NCT05520268

Brief Summary

This study evaluates the applicability and clinical efficacy of conventional music therapy and digital music rehabilitation for dementia in home and care home settings.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 29, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

3.3 years

First QC Date

August 23, 2022

Last Update Submit

February 3, 2025

Conditions

Keywords

music therapymusic-based rehabilitationdigital interventioncognitive functioningmemoryemotionmoodquality of lifeelectroencephalographymagnetic resonance imaging

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in the MoCA score at 3-month stage

    Montreal Cognitive Assessment (MoCA) score (range 0-30, higher score indicates better outcome), measures general cognitive function

    Baseline and 3-month stage

  • Change from baseline in the CERAD total score at 3-month stage

    Consortium to Establish a Registry for Alzheimer's Disease (CERAD) total score (Chandler score, range 0-100, higher score indicates better outcome), measures general cognitive function

    Baseline and 3-month stage

Secondary Outcomes (28)

  • Change from baseline in the MoCA score at 6-month stage

    Baseline and 6-month stage

  • Change from baseline in the CERAD total score at 6-month stage

    Baseline and 6-month stage

  • Change from baseline in the MoCA Fluency score at 3-month and 6-month stages

    Baseline, 3-month stage and 6-month stage

  • Change from baseline in the CERAD Fluency score at 3-month and 6-month stages

    Baseline, 3-month stage and 6-month stage

  • Change from baseline in the CERAD Naming score at 3-month and 6-month stages

    Baseline, 3-month stage and 6-month stage

  • +23 more secondary outcomes

Other Outcomes (6)

  • Association between baseline demographic and musical background factors and change in primary/secondary outcome measures (from baseline to 3-month and 6-month stages)

    Baseline

  • Association between baseline music cognition indices and change in primary/secondary outcome measures (from baseline to 3-month and 6-month stages)

    Baseline

  • Association between baseline ERP indices and change in primary/secondary outcome measures (from baseline to 3-month and 6-month stages)

    Baseline

  • +3 more other outcomes

Study Arms (3)

Conventional music therapy (CMT)

EXPERIMENTAL

Participants receive 10 weeks of CMT and standard care.

Behavioral: Conventional music therapy (CMT)

Digital music rehabilitation (DMR)

EXPERIMENTAL

Participants receive 10 weeks of DMR and standard care.

Behavioral: Digital music rehabilitation (DMR)

Standard care

NO INTERVENTION

Participants receive only standard care. Standard care comprises normal care services received by the PWDs in the Finnish health care system.

Interventions

CMT comprises both receptive and expressive musical activities (listening and reminiscing to music, singing, and moving to music) held in small groups (8 PWDs/group) for a duration of 10 weeks (2x60 min sessions/week) and led by a professional music therapist. For PWDs living in a care home, the CMT sessions are implemented as inpatient rehabilitation held at the care home. For PWDs living at home, the CMT sessions are implemented as outpatient rehabilitation held at a local day activity centre.

Conventional music therapy (CMT)

DMR comprises both receptive and expressive musical activities (listening and reminiscing to music, singing, and moving to music) held in small groups (8 PWDs/group) for a duration of 10 weeks (2x60 min sessions/week) and implemented using a novel digital music content service called HILDA. In HILDA, there are a number of stand-alone musical programs hosted by a virtual presenter which the PWDs can follow and through which they can interact. The DMR sessions are moderated by an instructor (care home staff member or research assistant). For PWDs living in a care home, the DMR is implemented as live sessions held at the care home using a HILDA box connected to a TV screen and operated via a remote controller by the instructor. For PWDs living at home, the DMR is implemented as virtual sessions using a video communication platform that allows the instructor to stream and control the HILDA service and the participants to see and hear each other and interact.

Digital music rehabilitation (DMR)

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed dementia (according to International Classification of Diseases \[ICD\] criteria), which is mild \[Clinical Dementia Rating (CDR) score: 0.5-1, Global Deterioration Scale (GDS) score: 3-4\], moderate (CDR: 2, GDS: 4-6), or severe (CDR: 3, GDS: 6-7) dementia
  • Age ≥ 60 years
  • Finnish-speaking (or bilingual; the study is performed in Finnish)
  • Stable physical and somatic condition (no major changes in psychotropic medication during the last 3 months)
  • Physically and cognitively able to take part in the intervention and assessments.

You may not qualify if:

  • Prior severe psychiatric illness or substance abuse
  • Major hearing or visual impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Helsinki / Faculty of Medicine / Department of Psychology

Helsinki, 00014, Finland

RECRUITING

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Teppo Särkämö, PhD

    University of Helsinki

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anni Pitkäniemi, MA

CONTACT

Lotta Ahveninen, MSci

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 23, 2022

First Posted

August 29, 2022

Study Start

September 1, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

February 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in articles, after deidentification

Time Frame
Immediately following publication. No end date.
Access Criteria
Researchers who provide a methodologically sound proposal.

Locations